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Abstract
Background: Assessing the consequences of research is an increasingly important task in research and innovation 
policy. This paper takes a broader view of those consequences than the conventional economic approach, placing 
researchers and their activities in the centre of the assessment process and examining results for professional practice 
and general education as well as contributions to knowledge.
Methods: The paper uses historical and documentary analysis to illustrate the approach, focusing on U.S. biomedicine 
over the past century. At aggregate level, the analysis attributes portions of the change in aggregate health indicators 
to research and research-based institutions, through several available types of logic: either through correlations 
between timing of institutional changes and changes in the indicators or through direct or indirect causal connections.
Results: The analysis shows that while biomedical research has certainly contributed to improved health in the United 
States, other factors have also contributed. In some ways the institutional structure of science-based medicine has 
worked against creating benefits for some groups in U.S. society.
Conclusions: The paper concludes with a call for more strategic attention to dimensions of impact other than 
knowledge outcomes and for participatory planning for research.
Background
An earlier version of this article was originally presented
in 1994 to a policy audience in Washington, DC. It
appears here at the invitation of the editors because it
raises issues that are still open in the assessment of bio-
medical research. The intervening years have seen the
introduction of much stronger processes in the United
States for strategic planning and accountability through
evaluation, as the article advocates. Yet the broader
dimensions of relationships between biomedical research
and society outlined here have not been incorporated
into those systems. The article's message is thus still per-
tinent; perhaps conditions are riper now for its accep-
tance. Updated information and additional references
suggested by HARPS reviewers have been added in Table
1, to maintain the original flow of the argument.
Quality of life goals for science and technology have
taken on new prominence in many industrialized nations
in the post-Cold War period in the United States.
National security has by no means disappeared as a rea-
son for maintaining national technical capacity, nor have
the benefits of research for innovation and economic
competitiveness been discounted. But healthy, educated
citizens and high-quality, high-paying jobs have moved
up in the list of priorities. And equally important, new
ways of reaching the older goals are being articulated.
The United States is not only concerned to be among the
world's leaders in science and engineering, but also to do
so in a way that lives up to America's ideals of equal
opportunity and utilizes all of its talents. Many nations
are aiming not just for a changing world, nor just for a
more technologically-intensive one, but also for a socially
and environmentally sustainable one. Objectives have
shifted from simply developing technology to doing so
responsibly, and the goal of "wealth" has transformed into
that of "prosperity."
My questions here concern how to achieve what we
want in these added dimensions of scientific progress and
technological change. What has basic research contrib-
uted to the quality of life as we define it today? How can
we judge whether current efforts are succeeding by these
criteria? How can we set goals and manage research to
achieve the returns in quality of life that we want, for our-
selves, for our children, and for our grandchildren?* Correspondence: scozzens@gatech.edu
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A crisp definition of quality of life goals eludes me in this
article, as it has eluded and probably will elude public dis-
cussion. All true national goals are fuzzy and permit
many definitions, because they represent broad consen-
sus rather than scholarly precision. National security and
economic competitiveness are goals of this sort, and
quality of life need not be any clearer. Like other national
goals, quality of life goals are translated through decision
making processes into quality of life objectives. The
objectives need to be proposed in context, debated pub-
licly, and put into operation in relation to specific pro-
grams, rather than set by fiat in a paper such as this one.
In addition, the term quality of life is likely to carry differ-
ent meanings in different cultural contexts. (See Table 1,
Row A for an additional context.)
In general, however, I use the term quality of life goals
to apply to goals with the following characteristics:
• They apply to the way the full range of humans live, 
including their diverse work, family, home, and com-
munity lives.
• They refer to objectives with importance above and 
beyond their economic exchange value.
• They refer as much to the way we do science and use 
technology as to the content of science or perfor-
mance characteristics of technology.
In short, they are goals that allow people to articulate
what they need from scientists and engineers in order to
live in a world of their own choosing.
Two kinds of goals that fit these criteria have emerged
over the years in research policy discussions. I refer to
them in this paper as what and how goals. Quality of life
Table 1: Selected Updated References
A There is a large literature within medicine on quality of life measurement. For example, the Centers for Disease Control in the United 
States measure "health-related quality of life" in terms of healthy vs. unhealthy days, as reported on health surveys. "Unhealthy days 
are an estimate of the overall number of days during the previous 30 days when the respondent felt that either his or her physical 
or mental health was not good." (http://www.cdc.gov/hrqol/methods.htm, accessed January 1, 2010). CDC reports that "in recent 
years, several organizations have found these Healthy Days measures useful at the national level for (1) identifying health disparities, 
(2) tracking population trends, and (3) building broad coalitions around a measure of population health compatible with the World 
Health Organization's definition of health." (http://www.cdc.gov/hrqol/methods.htm, accessed January 1, 2010). In this article, I use 
the term quality of life goal in a broader sense, to indicate a family of public goals articulated for research. The health-related quality 
of life measure are one example of indicators that could be used to implement planning and evaluation for such goals. For example, 
they could be used at the aggregate assessment level described in a later section of the paper.
B It would be interesting to compare the U.S. case with other national examples, such as the quite distinctive institutional 
developments in the United Kingdom. See Shergold, M and J Grant, Freedom and need: The evolution of public strategy for 
biomedical and health research in England, Health Research Policy and Systems 2008, 6(1):2-12.
C There is of course a substantial literature on the ways knowledge is co-produced with its social context. It is beyond the scope of this 
article to review that literature, but interested readers may wish to refer first to Nowotny, H, P Scott, and M Gibbons, Re-Thinking 
Science: Knowledge and the Public in an Age of Uncertainty. Cambridge: Polity Press, 2003.
D This dimension corresponds to knowledge utilization, which again has its own signficiant literature. As a starting point into this 
literature, the reader may wish to consult the work of Carol Weiss, for example her 1980 article "Knowledge creep and decision 
accretion," in Knowledge: Creation , Diffusion, Utilization 1: 381-404.
E Science communication has its own large literature and a central journal, Public Understanding of Science http://pus.sagepub.com. 
The emphasis on teaching as a form of science communication taken in this article as it was first written calls attention to systemic 
structural aspects of the science communication system that get little attention in the science communication literature.
F In the U.K., a whole new health research strategy was introduced in 2006, including institutional mechanisms designed to increase 
translational research and move research knowledge from "bench to bedside." For the strategy, see http://www.dh.gov.uk/en/
Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4127127, accessed January 1, 2010. For a description of 
the work of one of the new institutions, see http://www.nihr.ac.uk/about/Pages/default.aspx, accessed January 1, 2010.
G In the United States, the Washington Research Evaluation Network (WREN) played such a role; its efforts have been folded into an 
interagency group developing the Science of Science Policy (http://scienceofsciencepolicy.net, accessed January 1, 2010). There is 
an active branch of this community in the U.K. and the Netherlands, and the Swedish Research Council has helped to move the state 
of the art forward with two workshops (http://www.vr.se/forskningvistodjer/seminariedokumentation/medicin/
workshopnewfrontiersinevaluationofimpactsofmedicalresearch.4.72e6b52e1211cd0bba880005128.html, accessed January 1, 
2010).
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Page 3 of 13what-goals for research include health, education, and
environmental quality. Quality of life how-goals include
equity, democracy, and community. What-goals enter sci-
ence policy discussion most often as program objectives.
How-goals often enter as selection and evaluation crite-
ria.
The article begins by describing the general approach I
take to assessing progress toward quality of life goals. I
then sketch how that assessment might look if we con-
centrated on one area of research, biomedicine, and
looked back over two time perspectives in the United
States:
• a century-long perspective, going back to the time 
when, in very approximate terms, science-based tech-
nology and medicine began to be institutionalized on 
a large scale in America;
• a half century perspective, approximately since the 
addition of government support to the institutional 
matrix for scientists in the United States.
Having looked to the past, I then turn toward the
future, asking how we could use current research policy
and management methods to maintain progress toward
quality of life goals over the next twenty years, which
seems about the right time frame for thinking about
achieving quality of life results through shaping support
for researchers today.
I use U.S. biomedicine as an extended example in my
analysis (but see Table 1, Row B). Biomedicine has often
been invoked as the exemplar of strategic research, that
is, of fundamental science consciously organized to con-
tribute in the long run to the solution of practical prob-
lems. Judging by the levels of direct public involvement in
biomedical research policy, it is also clearly a high priority
for a wide range of citizens in affluent countries. Every
area of science, every public program that supports sci-
ence, however, sits in a slightly different ecology of rela-
tionships with practice and education. In the final
section, I discuss the applicability of the model I work
with to other areas of science, and point toward needs for
further research in this area.
The Conceptual Framework
Bringing people back in
In policy discussions, research is often described
abstractly: a national government supports "research";
"research" produces benefits for society. This form of lan-
guage follows the conventions of scientific writing, which
call on authors to remove themselves from their texts.
But it distorts our assessment of the connections between
research and quality of life by leaving the people who do
science out of view. In this particular bit of imagination-
stretching, I ask my readers to bring the people back in,
for two reasons. First, when we see research as the con-
crete activity of specific individuals, whose jobs involve
activities other than research and who also lead lives out-
side science, we bring both their institutions and their
communities back into view as well. This step is impor-
tant in assessing the full connections of research with the
quality of life.
Second, we need to bring the people back in to re-ori-
ent our thinking about the purposes of government sup-
port for research. I treat research here as the
advancement of knowledge in the sciences. But I treat the
central goal of government support of fundamental
research not as the production of knowledge per se, but
rather the maintenance and renewal of national technical
capacity in the form of researchers. By this, I do not mean
that national governments should support researchers
whether or not they are producing new knowledge; far
from it. Instead, I call attention to the consequences for
society that come from having researchers around, conse-
quences that go beyond the production of knowledge.
One of the most important consequences of bringing
the people back in to research policy is that it frees us
from thinking in terms of targeting knowledge produc-
tion. Instead of trying to plan what we need to know next
to move toward a quality of life goal, we can plan where,
in society or the economy, we want to develop technical
capacity. That is, we ask, where do we want researchers to
be, and who do we want them to be talking to? We can
then leave the question of what specific questions they
ask completely in their hands.
A Three Dimensional Model
To be able to trace the connections between researchers
and quality of life outcomes, I suggest a simplifying
scheme [1]. We can trace the results researchers produce
in three directions, which I will refer to as knowledge,
practice, and education.
• The primary job of the researcher is to produce 
knowledge that contributes to a research front. The 
researcher's contributions then become part of a 
larger pool of knowledge. (See Table 1, Row C.)
• The long-term benefits we associate with research 
begin when someone draws on that pool of knowl-
edge. That person might use the knowledge to 
improve practice, for example, in industry, medicine, 
or agriculture. What practitioners reads in the 
research literature can also change their concepts, 
frameworks, and world views, directly or indirectly. 
(See Table 1, Row D.)
• Or the person might draw on it in the context of 
teaching or science communication, to transmit the 
current best understanding of how the natural and 
technological worlds work to students and the general 
public. (See Table 1, Row E.)
It is precisely because the benefits of science come from
the pool of knowledge rather than directly from an indi-
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tions between basic research and the quality of life is so
difficult when one thinks of research only in terms of
knowledge outputs.
When one focuses on researchers themselves as the
primary product of government support programs, how-
ever, the other routes through which benefits are accom-
plished spring into view. For example,
• the researcher may use his or her expanding exper-
tise and familiarity with the knowledge pool directly 
in practice, by consulting (as engineers do often, with 
public and private organizations), by combining prac-
tice and research in the same job description (as med-
ical researchers who are also active clinicians do), or 
by serving as an advisor to a governmental or non-
governmental organization at national, state, or local 
levels.
• Some researchers, those who do graduate training, 
also contribute to practice by training professionals. 
When they leave their training in a research setting, 
professionals are up to date on the contents of the 
knowledge pool and equipped with the inclination 
and skills to dip into it later when they need it.
• In an analogous way, researchers on university cam-
puses contribute to the utilization of the knowledge 
pool by providing up to date undergraduate teaching, 
and creating a life-long love of learning among col-
lege-educated people. Among Americans, for exam-
ple, half go to college, and the other half are taught by 
people who went to college. The quality of undergrad-
uate science education and the extent to which it cre-
ates a sense of competence with regard to technical 
matters thus has a very wide influence on quality of 
life in the United States.
I organize my discussion of the quality of life results of
basic research along these three dimensions--knowledge,
practice, and education.
Approaches to assessing quality of life outcomes
Before turning to my example, biomedicine, I must ask
the indulgence of my readers through one more set of
rather abstract considerations, which they will want to
follow in relation to the example. Quality of life outcomes
of basic research, like its economic outcomes, can be
assessed either at aggregate or at program level. The logic
of the assessment is different at these two levels, and the
way the two sets of analyses interact is important in
building up a knowledge base on quality of life returns.
At the aggregate level, the assessment begins by identi-
fying indicators of the relevant what-goals--in the bio-
medical case, for example, indicators of health. Given that
the goals themselves are broad, multiple indicators will
undoubtedly be available, and experts will not all agree on
any single key indicator. But there is likely to be broad
agreement, at least retrospectively, about the direction of
progress implied in the indicators as a set.
The analysis then attributes portions of the change in
the indicators to research, through several available types
of logic. One can use the timing of the research contribu-
tions and change in the indicators, as, for example, in this
analysis of the contribution of medical research to health
outcomes:
The tide of infectious and nutritional diseases was 
rapidly receding when the laboratory scientist moved 
into action at the end of the past century.... In reality, 
the monstrous specter of infection had become but an 
enfeebled shadow of its former self by the time 
serums, vaccines, and drugs became available to com-
bat microbes [2].
Alternatively, one can trace direct causal connections,
for example, between the introduction of a vaccine and a
subsequent dramatic drop in the incidence of a disease,
or indirect causal connections, for example, through the
facilitation of an approach or technique, or the incorpo-
ration of the knowledge into a technology.
A genre of research called "retrospective studies" has
demonstrated the general usefulness of such explorations
of the rich network of connections linking research with
outcomes. Most early retrospective studies, however,
started with specific advances in an area of practice and
traced the events that led to them [3,4]. To judge quality
of life outcomes, one must use a broader set of indicators,
since some of the data may show lack of or the opposite of
progress. Clearly, it is just as important to ask why some
problems are getting worse and what research capacity
we need to reverse those trends as it is to assess what
research has contributed to past progress toward quality
of life. It is also important to examine both how-goals and
what-goals in such an analysis--that is, for example, not
just whether biomedical research contributed ultimately
to health, but whether it did so in a way that contributed
to or detracted from equity, and contributed to or
detracted from the empowerment of citizens.
At the program level, the analysis begins from the oppo-
site end of the causal chains, in the activities of the
researchers themselves. It tracks their immediate out-
puts--knowledge production, usually in the form of pub-
lications; direct contributions to practice and indirect
ones through the training of professionals; and contribu-
tions to the educational stream through undergraduate
teaching and general science communication activities.
Using the set of institutional and social linkages that ret-
rospective studies have identified, the analyst can then
see where and how the researchers in the program are
contributing, not in terms of direct production of out-
comes, but by setting in motion the sorts of processes we
expect to produce outcomes.
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"what" and "how" varieties, and cannot be evaluated by
whether they have moved the entire set of quality of life
indicators in a particular direction. Government-level
leadership, however, can compare the sum total of indica-
tors in a particular quality of life area with the sum total
of contributions and consequences that result from pub-
lic programs and assess whether the portfolio of pro-
grams is connected richly enough to the institutions that
produce what-outcomes and is operating in a manner
that will produce how-outcomes. Thus aggregate retro-
spective studies combine with program assessments to
give high-level decision makers the needed information
base to manage for quality of life outcomes. I return to
these activities in my discussion and conclusions.
Results
What has research contributed to quality of life?
We do not know as much as we could about the connec-
tions between researchers and the changing quality of life
in America; but we do know some things. This section
provides only a broad-brush view, based on commonly-
accepted observations, to sketch in the categories of link-
ages discussed above in relation to the example of bio-
medicine. It does not provide an assessment itself, but
rather points the way to one. I concentrate here on the




In U.S. biomedicine, the century-long viewpoint takes us
back to an era of a major reform in medical education in
America [see [5-8]]. In the post Civil War years, doctors
were a weak professional group in American society,
competing with each other for a small market and with
no special claim to authority over medical care. For
admission to medical school, only a high school educa-
tion was required. The medical curriculum followed no
special order, and the graduation requirements were min-
imal. In 1871, Harvard led the way to raising standards,
extending the academic year from four to nine months
and the full course from two to three years. Other institu-
tions found they could not afford not to follow suit. In
1890, the new Association of American Medical Colleges,
which included the most progressive one third of medical
schools, set minimum requirements of three years, six
months a year, with laboratory work in histology, chemis-
try, and pathology.
In 1893, the Johns Hopkins University opened its medi-
cal school, embodying "a conception of medical educa-
tion as a field of graduate study, rooted in basic science
and hospital medicine, that was eventually to govern all
institutions in the country. Scientific research and clinical
instruction now moved to center stage" [[5], p. 115]. Hop-
kins recruited faculty nationally instead of locally;
required two years of pre-clinical sciences and two on the
wards; and created advanced residencies in specialized
fields. We now talk of "partnerships" with regard to
research: Hopkins invented them in biomedicine, estab-
lishing a hospital in connection with the medical school,
joining science firmly to clinical hospital practice. Hop-
kins graduates exported this model around the country
over the next decades.
Disparities grew between schools following this model
and smaller, commercial or special-interest institutions,
and reached a watershed early in the twentieth century.
In 1910, a young Hopkins-connected educator, Abraham
Flexner, was hired by the American Medical Association
to study the quality of education at American medical
colleges. His report recommended closing most of them:
he would have kept only 31 out of 131. In the wake of the
report, many did not survive, and those that did raised
their standards. An influx of private philanthropic sup-
port reinforced this shift. Rockefeller's General Education
Board channeled $91 million into medical schools over
the next two decades, with seven institutions receiving
over two thirds of the funds. Its staff actively encouraged
medical education more closely linked to medical science
than to medical practice. "These policies determined not
so much which institutions would survive as which would
dominate, how they would be run, and what ideals would
prevail" [[5], p. 121].
Knowledge
Thus the seeds were sown for the post-War growth of
government-sponsored biomedical research. Aside from
the institutional base built through private philanthropy
at a small group of research hospitals, only a few govern-
ment-sponsored health-oriented research institutions
existed before the Second World War. These included a
small Laboratory of Hygiene that would grow up to be the
National Institutes of Health.
Two important aspects of the pattern of biomedical
research in the 20th century appeared during this period.
On the one hand, science within the medical school con-
text was more likely to be linked to medical practice than
science done outside; thus from the viewpoint of
researchers themselves, the knowledge-practice link was
forged in the Hopkins model. Assuming that research
knowledge was to be useful to medical practice, the alter-
native was that researchers should be located outside
medical institutions--clearly a second choice. On the
other hand, under the science-based model as it actually
developed, the technical capacity developed through
research, embodied in the researchers themselves and
those they trained, was highly concentrated in a few insti-
tutions. As a result, from the viewpoint of medical practi-
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medicine and general medical practice.
Practice
The gap took several forms. First, at the individual level,
"academic and private physicians began to diverge and
represent distinctive interests and values" [[5], p. 122].
Thus, while medical science could respond to clinical
problems as they appeared in the context of the great
teaching hospital, most doctors might find the research
results distant and hard to assimilate into their practice.
In addition,
the medical profession grew more uniform in its 
social composition. The high costs of medical educa-
tion and more stringent requirements limited the 
entry of students from the lower and working classes. 
And deliberate policies of discrimination against 
Jews, women, and blacks promoted still greater social 
homogeneity. The opening of medicine to immigrants 
and women, which the competitive system of medical 
education allowed in the 1890s, was now reversed. 
[[5], p. 124]
Second, at the community level, the move to scientific
medicine created great disparities. Flexner's recommen-
dations to reduce the number of medical schools to 31
would have left twenty states without any medical
schools. In the end, over 70 survived, and state legisla-
tures stepped in to assure at least one institution in virtu-
ally every state. Even these institutions did not produce
doctors for every community, however. "Before the Flex-
ner report, there had been seven medical schools for
blacks in the United States; only Howard and Meharry
survived" the 1910 watershed. (For the impact of the Flex-
ner report at Howard, see [9].) African Americans faced
outright exclusion from internships and hospital privi-
leges at most institutions. In 1930, only one out of every
3,000 black Americans was a doctor, and in the Deep
South, the ratio was one in over 14,000. One can only
imagine what the comparable numbers were for, for
example, Asian Americans and American Indians. One
might assume that European American doctors were pro-
viding adequate health care for African Americans as
well, but segregation and racism must surely have inter-
vened. (See the account in [10] as an example.) Doctors
from communities that lost access to medical expertise in
the wake of the Flexner report complained that while
their local medical training might not be the equivalent of
Harvard's or the University of Pennsylvania's, it was bet-
ter than having no doctors at all in poor and rural com-
munities. "Would you say," one wrote, "that such people
should be denied physicians? Can the wealthy who are in
a minority say to the poor majority, you shall not have a
doctor?" [[5], p. 125] The implicit answer was, "Yes."
Education
Another consequence of the way U.S. biomedical
research was established institutionally was its isolation
from the general educational stream. Biomedical
researchers were medical school faculty, and did not gen-
erally teach undergraduates, even at Harvard, Johns Hop-
kins, or any of the other universities where they were
located. What biomedical researchers were learning
about basic biology, then, had to be diffused through the
general pool of biological knowledge before it could reach
college students, and through them the school curricu-
lum. The routes for diffusion of research knowledge to
general medical practitioners were strong in comparison.
Thus the institutional location of biomedical research
contributed to a growing gap in expertise between medi-
cal practitioners and their patients.
Outcomes
From the advent of scientific medicine to the Second
World War, the average health of Americans certainly
improved. But medicine itself, and scientific medicine in
particular, is generally credited with only a small part of
this improvement. A working group of the Carnegie
Commission on Science, Technology, and Government
gives considerable credit to factors other than research:
The health of the American people, as judged by life 
expectancy, has been improving since the turn of the 
century. Initial improvements in longevity primarily 
reflected diminished mortality from infections and 
were largely attributable to improvements in sanita-
tion and nutrition and to the development of effective 
vaccines. Sulfonamides, penicillin, and other antibiot-
ics contributed to a further decrease in death rates 
[11].
In short, specific preventive and therapeutic measures
developed during this period probably only accelerated a
decline in mortality rates that was already underway.
To focus only on such aggregate assessment of the
products of biomedical science, however, misses half of
the challenge of examining quality of life issues. What
matters is not only what we have done, but how we have
done it. To complete this analysis, we would have to ask
about the differential distribution of health outcomes
among the American people. We would have to take into
account the continuing exclusion of many population
groups from the medical profession generally and from
biomedical research careers specifically in the first half of
the twentieth century. And we would also have to take
into account the relationship of patients and their families
to doctors and the medical system generally. I return to
this topic in the next section.
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Knowledge
Research within the medical context received a tremen-
dous boost in the post-War period, and continues to
dominate the profile of government-sponsored basic
research. The story is quite well known. Following stun-
ning contributions to the war effort, researchers gained
dominance in the Public Health Service in the late 1940s.
Two wealthy women, Mary Lasker and Florence
Mahoney, raised the public profile of biomedical research
and stimulated a coalition among researchers, members
of Congress, and segments of the mobilized public, which
resulted in a phenomenal growth rate in funding in the
1950s. The new biomedical coalition adopted a strategy
of seeking funds under the rubric of specific diseases, and
the now-plural National Institutes of Health subdivided
rapidly on this basis. Researchers retained a remarkable
degree of control over research, through institutional
mechanisms such as peer review (see discusion in [5],
drawing on [12,13], and [14].)
In terms of the content of knowledge itself, by far the
most prominent trend has been the move toward the
molecular level of analysis. Within the framework of dis-
ease-oriented institutes, biomedical researchers are now
more tied to each other in their exploration of the funda-
mental dynamics of genetic expression. Moving to this
level of analysis has also reunited biomedical knowledge
with the rest of biology more powerfully than before.
Researchers
The enormous quantitative increase in the amount of
biomedical research activity has brought with it a
broader, more complex institutional base of researchers.
Three quarters of NIH's current extramural research is
done in higher educational institutions; just over half of
the support goes to medical schools alone [15]. Outside
the medical schools, large numbers of applications come
from biology, chemistry, and biochemistry departments,
but two thirds are spread across the rest of the university.
About 20 percent of extramural funding goes to non-
profit research institutes, independent hospitals, and
other non-profit institutions. Geographically, while the
funds are by no means distributed evenly on a per capita
basis, every state gets something: even Wyoming, ranked
last, had over $7 million in NIH funds in 2007 [16]. About
one in four NIH applications has traditionally been from
a person with a medical degree [17]. Industry has also
built its technical capacity by hiring biomedical research-
ers, a trend that was only beginning in the 1930s and did
not become a major activity until after the war. Pharma-
ceutical firms have significant in-house research efforts,
and the medical device industry is also quite research-
intensive, using researchers with many kinds of expertise
including biomedical.
Minority communities, however, continue to lack
access to this technical capacity. Biomedical research is
still largely a white domain in America, more white than
medical practice itself. In the 1990s, an advisory body of
minority researchers and practitioners chose building
minority biomedical technical capacity as the keystone of
the Minority Health Initiative at the National Institutes of
Health. A counterpart group considering women's health
issues had focused on the shorter-term strategy of
addressing the knowledge base with regard to specific
female health problems like menopause and breast can-
cer; only in later rounds of resource allocation did the
question of training programs for female researchers
arise. But the minority group allocated over half of the
available resources from the beginning to training pro-
grams, thus affirming the perceived importance of the
equitable distribution of technical capacity among Amer-
icans [18,19].
Practice
The connections between present-day biomedical
research and various kinds of practice are clearly rich.
Biomedical researchers themselves consult, own biotech-
nology and drug firms, and are practicing physicians,
among other roles. In medical schools, they train new
generations of doctors and provide continuing education
for doctors already in practice. Through graduate training
for researchers who end up in industry and continuing
collaborative relations with industrial researchers, they
build the technical capacity of pharmaceutical and other
firms, maintain personal connections between industrial
and academic research, and increase the likelihood that
industrial researchers will have the knowledge and incli-
nation to draw on the pool of biomedical knowledge as
they need to in their work. As we saw in the earlier
period, from the viewpoint of researchers, institutional
locations create a powerful network keeping them aware
of practical problems and providing channels for their
research results to be incorporated into practice.
From the wider viewpoint of medical practice, however,
the network may not appear so effective. Certainly a large
proportion of physicians are learning the basic sciences at
a high level in their medical curriculum, and are therefore
prepared as well as possible for the struggle to keep up
with research results that appear after they are in prac-
tice. As the pool of biomedical knowledge spreads to
become a lake and then an ocean, however, the challenge
of continuing education for physicians looms large. The
physician's most common information on research
results may be the media and drug salesmen. As doctors
move through their three decades or so of practice, they
inevitably find themselves further and further from the
research front, and incorporate new therapeutic
approaches with more difficulty and less understanding
into their work.
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of biomedical research are mediated through the training
of medical practitioners and the symbiotic relationship
between science-based medicine and medical technology.
There is a growing body of anthropological evidence
examining the relationship between patients and the
medical system as a factor shaping a personal sense of
autonomy and empowerment. In this analysis, the grow-
ing scientific knowledge of medical practitioners can
increase a sense of powerlessness in patients. This sense
is exacerbated by medical technology, which transports
one's experience of one's own body outside the body, onto
imaging screens and into numerical test results. The
women's health movement has been particularly vocal in
drawing attention to the disempowerment that can result
from standard doctor/patient or patient/hospital interac-
tions (see, for example, [20-22]). The point applies with
even more force to poor communities, whether rural or
urban. Given the number of interactions Americans have
over a lifetime with medical care providers, any such
sense of disempowerment can accumulate to the point of
leading to a larger sense of alienation from authority. The
situation is thus of no inconsiderable consequence for
general levels of democratic participation.
Education
One clear benefit from the vast growth of biomedical
knowledge and the push to the molecular level is the
increased probability of integrating biomedical results
with those of the rest of biology. As mentioned, biomedi-
cal research is no longer confined to the medical schools
within the university. Biology and chemistry teachers,
who regularly teach undergraduates, are also contribut-
ing to the biomedical effort. Thus it is not surprising that
the basic results of biomedical research are making their
way into college textbooks, and thus on to school level
science training. The limitations on this diffusion route
come largely from the problems of the educational system
itself. The gap between what biomedical researchers
know about the human body and what high school stu-
dents in the nation's weakest schools know is undoubt-
edly widening. Likewise, other parts of the public are
differentially exposed to new concepts in medicine. Most
of modern genetics, for example, has been discovered in
the time since the President's generation took high school
biology. Public broadcasting documentaries, science sec-
tions of newspapers, and science museums combined do
not reach more than a small segment of that generation
with the simplest of knowledge of the major themes of
contemporary biomedical research. Physicians and other
health care providers can end up being the major science
educators, but in relation to specific conditions and at
times of stress. Thus the physician/patient relationship
takes on yet another significant role in shaping the char-
acter of life with science for Americans.
Outcomes
An overall assessment of the outcomes of post-War bio-
medical research is of course a matter for debate and dis-
cussion. The high cost of health care is an issue: per
capita health care spending in the United States has
increased at a faster rate than per capita income for a
number of decades [23]. And whether the gains in health
were related to those costs, or to the investment in bio-
medical research, is controversial. Again I quote from the
Carnegie Commission report as a sympathetic summary:
In recent years, increases in life expectancy have 
resulted primarily from reductions in cardiovascular 
death rates from stroke and coronary artery disease. 
These improvements reflect control of hypertension, 
a decrease in the prevalence of smoking, decreases in 
the intake of fats and cholesterol, better weight con-
trol, and healthier lifestyles. There have also been 
substantial reductions in death rates from certain 
types of cancer, owing to improvements in surgery, 
radiation, and chemotherapy. Unfortunately, 
increases in lung cancer due to smoking have approx-
imately canceled out the successes with other forms 
of cancer. [[11], p. 42]
The aggregate numbers again mask differences in out-
comes for different groups in the population. Between
1980 and 1990, the overall life expectancy at birth for
Americans increased from 73.7 to 75.4 years. But life
expectancy for the white population increased by 1.7
years and in the black population by 1.0 year, thereby wid-
ening the gap between the two. In 1990, the infant mor-
tality rate for Americans as a group was 9.2 deaths per
1,000 live births, but it was 7.6 for white mothers and 18
for black mothers--and again the gap had widened
between 1980 and 1990 [[24], p.1].
Discussion
The next twenty years
It is worth pausing at this point to examine how my anal-
ysis has proceeded. I have tried to raise the issue of the
relationship of biomedical research to quality of life
through several strategies. By using the perspectives of
century and half century, I have forced us to look at the
issue in terms of long-term relationships built up through
institutional structures and patterns of interaction
shaped by education, rather than just in terms of research
results and their incorporation into medical practice. By
focusing on researchers instead of research knowledge, I
have reinforced the focus on institutions and the distribu-
tion of technical capacity among Americans and Ameri-
can communities. By using health statistics, I have forced
us on the one hand to think about the larger set of prac-
tices through which the benefits of biomedical research
must reach the public, and in particular about the distrib-
utive aspects of the medical care system. On the other
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research, we have been forced to put the specific agendas
and accomplishments of particular research communities
into a broader perspective of life in America. The result-
ing discussion bears certain resemblance to now-familiar
aggregate assessment of the contribution of basic
research to the economy.
As with aggregate economic assessment, however, such
broad-brush assessment of quality of life issues provides
little direction to researchers, research managers, or pol-
icy makers in how to achieve quality of life goals. The
question becomes pressing: How do we get from where
we are now to where we want to be? I argue in this section
that the conventional tools of research policy and man-
agement--goal-setting and program evaluation and plan-
ning--are appropriate to this task and that there has been
progress in putting them to work.
Quality of life goals do put at least two new new
requirements on research policy, however. The first is to
think in terms of long term institutional and community
development - something akin to the 100-year view in the
analysis presented here. The second is the inclusion of the
public--or to be more precise, publics--in all these pro-
cesses. Just as we brought people back in to the concept
of what government support for research is about, we
must bring people back in to research management.
Researchers themselves are not the experts on quality of
life outcomes; they are partners in producing them. All
the partners need to be involved in running the firm.
Goal setting
In the years preceding the first version of this article, the
variety and insistence of calls to set goals for research in
the United States had been striking. The Carnegie Com-
mission report, already quoted, stressed the need to set
long-term goals, rather than squander technical
resources on short-term objectives with no vision of the
future in mind.
If this emphasis continues, the problems we have 
encountered in recent years, such as erosion of the 
nation's industrial competitiveness and the difficulties 
of meeting increasingly challenging standards of envi-
ronmental quality, could overwhelm promising 
opportunities for progress. However, we believe there 
is an alternative. The United States could base its S&T 
policies more firmly on long-range considerations 
and link these policies to societal goals through more 
comprehensive assessment of opportunities, costs, 
and benefits. [[11], p. 11]
The report gave a long list of examples of major societal
goals to which science and technology contribute, includ-
ing personal and public health and safety, creation and
maintenance of civic culture, and environmental quality
and protection. It proposed a National Forum on Science
and Technology Goals to facilitate "a balanced and effec-
tive interaction ... between the scientific and engineering
communities and those representing a broad range of
other societal interests." [[11], p. 13]
The call for goals had also been voiced within govern-
ment. An influential senator had called for 60 percent of
the National Science Foundation's budget to be devoted
to strategic research, in areas such as high performance
computing, biotechnology, materials science, and manu-
facturing [25], and the White House had taken up the
challenge in its guidance for the budget process [26]. For
biomedical research, a goals document of approximately
the kind envisioned in the Carnegie Commission report
existed: Healthy People 2000: National Health Promotion
and Disease Prevention Objectives. "After extensive pub-
lic review and comment, involving more than 10,000 peo-
ple, the objectives were revised and refined to produce"
the final report in 1990 [[27], title page]. The process of
producing the report would seem to be a model for the
sort of National Forum the Carnegie Commission had
recommended.
Still, Healthy People 2000 illustrated the lack of connec-
tion between research program planning and long-term
national goal setting. The Carnegie Commission noted
the problem:
There is a mismatch between the long-term societal 
goals necessary for our society's well-being in the 21st 
century and many of the present scientific goals of 
research. The implications for biomedical research of 
a new social goal of cost-effective and equitable 
health care delivery to the entire U.S. population have 
not yet been carefully analyzed. [[11], p. 43]
The first version of an NIH strategic plan, announced
to the press in the summer of 1992 but never released,
seemed not to have taken Healthy People and its national
goals into account.
Since the mid-1990s, strategic planning with stake-
holder consultation has become a requirement for all U.S.
federal government agencies, under the Government Per-
formance and Results Act and later versions of results-
oriented management. Healthy People 2010 was con-
structed in this environment, again through a broad par-
ticipatory process [28]. Under Congressional mandate,
the National Institutes of Health now produce strategic
plans every three years and its budget reflects the goals
and objectives of the plan. The NIH budget for 2008, for
example, reported briefly its connection to Healthy Peo-
ple 2010 along with the strategic plan of its parent depart-
ment, Health and Human Services, referring the reader to
its performance goals for details [29]. But one can see lit-
tle direct connection between the very general strategic
priorities of NIH ("support new investigators," a bridge
award, and a common fund for new initiatives [[30], p, 4])
and those of Healthy People 2010 ("increase quality and
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[28]) The intersections begin to appear among NIH's
"strategic research objectives" and other performance
goals. But among the 70 specific objectives (chosen as
illustrative, not comprehensive), only two refer directly to
the Healthy People document. A few more are aimed at
"health disparities" or "underserved groups." But still it
appears that even a government-wide effort asking agen-
cies to articulate strategic goals has not produced much
obvious alignment between the national health plan and
the biomedical research plan for the United States (see
Table 1, Row F for a related U.K. example).
Program planning and evaluation
The question of how to get from here to our goals is actu-
ally answered in the process of program planning. In the-
ory, this process translates broad government goals and
objectives into specific program activities and budget
requests. In practice, over the past decade, this process
should have been engaging agency program planning
much more powerfully with national goal setting,
because of the new planning and budgeting processes
introduced in the mid-1990s.
The language of planning tends to raise fears among
scientists that policy makers are asking them to plan
research. When we think of the goal of a research pro-
gram as putting active researchers in certain kinds of con-
texts, however, the reason for the fears disappears. When
we bring people back in, program planning for basic
research programs no longer involves controlling the
contents of research projects, but instead pays attention
to where researchers are working, who they talk to, what
communities they empower, and what else they do
besides research.
Exactly what these criteria entail will vary from pro-
gram to program. NSF's Engineering Research Centers
and Science and Technology Centers serve as an example
of how this approach can be used; the new U.K. Biomedi-
cal Research Centres are another [31]. The NSF Centers
are not told in detail what to study, but they are required
to show that they are embedded in a set of partnerships
that is likely to move their research results into practice,
and they are required to make a commitment to under-
graduate education as well as graduate. When these
broader functions of research become the focus, it is
important to think in terms of aggregates of researchers
rather than individual ones; no individual researcher
needs to perform equally on all three dimensions of eval-
uation, but rather a set of researchers should do so. Thus
it is the sum of centre-affiliated researchers that maintain
the connections in three directions: knowledge, practice,
and education. Likewise, any government research pro-
gram can be seen as a sum of researchers, who together
contribute to the knowledge base, maintain connections
to practice, and enhance education.
The difference between a centre and a program, in this
comparison, is that the centre is required to have a strate-
gic planning process that directs research toward topics
that the specific clients of the centre find important.
Researchers and clients together participate in that pro-
cess. A program consisting of a portfolio of individual
grants (from individuals or teams) does not need to
determine centrally what topics the investigators study.
But it does need processes in which researchers and their
partners together discuss how the total research ongoing
in the program relates to its primary contexts of use, so
that researchers themselves remain aware of these con-
texts and can take them into consideration in their own
choice of research topics. The process of program plan-
ning provides one such opportunity, but the investigators
themselves are seldom involved in that process. Program
evaluation processes, however, which usually involve
extensive interaction with program participants, offer a
better setting for this negotiation [32].
Program evaluation for a program aimed at technical
capacity asks, not "Have the researchers in this program
answered a specific question?" nor "Have they achieved
some particular result?" but
• Are they doing excellent research?
• What are they learning from it, and who else is 
learning it?
• Who draws on the pool of knowledge these 
researchers contribute to?
• Are these researchers talking to the people who use 
that pool of knowledge, to remain aware of the long-
term practical problems it relates to?
• Are these researchers empowering citizens and con-
sumers, directly or indirectly, with the knowledge 
they produce and how they produce it?
The information gathered in the evaluation can be used
to shape the program, for example, by shedding light on
the mix of resources investigators need to do excellent
research and facilitate its use, or by identifying new part-
ners or ways of interacting with partners that can
increase the program's effectiveness. The evaluation pro-
cess itself raises the awareness of both researchers and
partners to the way the program actually works to con-
tribute to quality of life goals, that is, how it sets processes
in motion that end up in those results. In an untargeted
program, the process of evaluation thus serves some of
the same functions that the strategic planning process
serves for a centralized research unit, but does so in a way
that leaves choice of research topics and judgment of
technical excellence entirely in the hands of researchers.
To achieve quality of life goals through such pro-
grammes, however, the key is who is involved in program
evaluation and planning. To see the whole set of linkages
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tion panels need only a minority of researchers, but a
majority that includes a wide range of people with other
kinds of knowledge. One important set of such people is
usually called "next-stage users" of research. These are
people with knowledge of practice applications (like phy-
sicians, nurses, and counselors in biomedical research).
The other important set of participants is end-users, that
is, those who have experienced and thoughtfully consid-
ered the ultimate results of the researchers' work. For bio-
medicine, all members of the public are potentially end-
users in this sense. Just as with the selection of research-
ers for evaluation committees, the challenge is to find
participants with broad enough perspective and relevant
experience to cover the range the committee needs. Find-
ing such people is worth the effort, however. Unless the
processes of program evaluation and planning include
quite a wide range of such partners, they will not be able
to judge quality of life outcomes effectively.
At the highest level, NIH has increased public involve-
ment in shaping its programs. The NIH Director estab-
lished the NIH Council of Public Representatives in 1999
[33]. The group includes medical practitioners and health
advocates from a variety of disease and population
groups. The Council issued a report in 2004 on enhanc-
ing public involvement in priority setting [34], urging the
biomedical research community to "active listening" to
those it intends to serve. The Council sets a new standard
for NIH in public involvement.
The earlier analysis reported health outcomes for the
decades examined. It would be naïve to trace any of the
small changes we have seen in biomedical planning and
evaluation directly to health outcomes in the United
States. Nonetheless, let us end with at least one sign of
movement in the right direction. Although the gap in life
expectancy between white and black Americans
remained unacceptably large, at least in the mid-2000s,
the trend was in the right direction [Figure 1].
Conclusions
The last section began to address the question of whether
the framework I have been developing applies outside
biomedicine. Parts of it, in particular the link between
researchers and practice goals, are well developed in U.S.
military R&D. Next-stage users are involved in many
planning and evaluation processes for research there and
in industry-oriented programs. End-stage users are
involved in a few, including some military R&D assess-
ment processes and NIH's councils. In disciplinary sci-
ence programs in the United States, a different mix of the
three dimensions is appropriate, with more emphasis on
educational responsibilities, more diffuse relationships to
practice, and more involvement of users within the sci-
ence community, drawn both from the discipline sup-
ported by the program and from other disciplines that
depend on its knowledge pool. Any government program
of research can be seen profitably within the framework,
however, as long as the appropriate weight is put on each
of the three dimensions.
Two related bodies of knowledge and experience need
to be built up extensively, to put this framework into
practice effectively. First, we need to know much more
about the activities and institutions that link basic
research to quality of life outcomes. These are identifiable
in specific cases, but there is no general body of knowl-
edge, equivalent to the body of knowledge about indus-
trial innovation processes, to provide general concepts in
this area. Without general concepts, every retrospective
study and evaluation process starts de novo to identify
these links, and the overall effort required is much
greater. A small community of researchers devoted to
understanding these links is developing, through work-
shops and research projects, to play a role for quality of
life outcomes that parallels the role of economists of R&D
in relation to industrial innovation (see Table 1, Row G).
Second, we need to build up experience with locating
appropriate public members of evaluation and planning
panels, and utilizing their insights effectively. NIH has
traditionally looked to organized patient and patient-fam-
ily groups as members of its councils, as well as non-sci-
ence professionals who bring different perspectives to the
process. The new Council of Public Representatives
strengthens this system. The U.K. has been working
actively on public involvement for decades, through an
effort now called INVOLVE [35]. These are positive
steps, and can provide the beginnings of creative thought
about broader representation. Once representatives of
various public are on these panels, however, chairs and
executive secretaries can easily be at a loss as to how to
give them an effective voice. In the absence of a set of
guidelines for effective public-researcher interaction in
Figure 1 Black-White Difference in Life Expectancy at Birth. 
Source: http://www.cdc.gov/nchs/data/hus/hus07.pdf#027, accessed 
6 July 2008.
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Page 12 of 13research decision making processes, such committees are
open to unconscious domination by the research com-
munity, a process that defeats the purpose of public rep-
resentation. If we are serious about achieving quality of
life returns from basic research, we cannot afford to lose
the benefit of the expertise of public members of these
groups. We should therefore make concerted attempts to
collate the experience to date with mixed committees of
this sort, and build a base of research knowledge that can
provide practical guidance to chairs and executive secre-
taries of future committees.
There is thus a great deal of work to be done to use the
framework I have discussed in this paper to increase the
effectiveness of programs with regard to quality of life
goals. The challenges involve both of the ways I have dis-
cussed here of bringing people back in.
• Putting the researcher back at the center of research 
evaluation and planning concepts. We have focused 
too long and too exclusively on the knowledge prod-
ucts of research. Thinking about researchers as multi-
dimensional contributors will take some imagination, 
and then some effort in translating that understand-
ing into appropriate program structures and 
resources.
• Putting the public back in evaluation and planning 
processes. Public involvement in research manage-
ment has been seen for too long as a threat to auton-
omy and a form of political control. In the framework 
I have outlined, the opposite is true. Public involve-
ment in program evaluation and planning may be the 
only route, under current circumstances, to leaving 
researchers in control of their research topics and 
processes. Furthermore, it is a necessary condition for 
using technical capacity to contribute to quality of life 
goals, since researchers themselves have part of the 
expertise, but not all the expertise, needed to identify 
the complex links between research and these out-
comes.
In short, I call for a quiet revolution in science policy, a
transformation within existing structures and processes
that will maintain, utilize, and expand the important
strengths of current basic research systems.
Competing interests




This article was originally prepared for the Joint Conference, National Science 
Foundation, American Enterprise Institute, Brookings Institution on "The Con-
tributions of Basic Research to the Economy and Society," Washington, DC, 3 
October 1994. That version appears as pages 184-209 in Bruce L. R. Smith and 
Claude E. Barfield, Technology, R&D, and the Economy (Washington, D.C.: 
Brookings Institution and American Enterprise Institute, 1996) and is repro-
duced with the permission of Brookings Institution Press. The author thanks 
two reviewers for their helpful pointers to areas where practice in impact eval-
uation has moved forward since the original was published. The views 
expressed in this document are the author's alone and do not necessarily rep-
resent those of her institution or any of the sponsoring organizations.
Author Details
Technology Policy and Assessment Center, School of Public Policy, Georgia 
Institute of Technology, Atlanta GA 30332-0345 USA
References
1. Cozzens SE: Strategic Evaluation and the Keystone Model of Basic 
Research.  In Science and Technology Policy Yearbook, 1994 Edited by: Teich 
AH, Nelson S, McEnaney C. Washington, DC: American Association for the 
Advancement of Science; 1995. 
2. Dubos R: The Mirage of Health Rockefeller Medicine Men Edited by: Richard 
Brown E. Berkeley: University of California Press; 1979:220. 
3. Comroe and Dripps: Scientific Basis for the Support of Medical Science.  
Science 1976, 192:105-111.
4. Institute for Defense Analysis: DARPA Technical Achievements Arlington, VA; 
1991. 
5. Starr P: The Social Transformation of American Medicine New York: Basic 
Books; 1982. 
6. Stevens R: American Medicine and the Public Interest New Have: Yale 
University Press; 1971. 
7. Rosenberg CE: The Care of Strangers: The Rise of America's Hospital System 
New York: Basic Books; 1987. 
8. Stevens R: In Sickness and in Wealth: American Hospitals in the Twentieth 
Century New York: Basic Books, Inc; 1989. 
9. Manning KR: Black Apollo of Science: The Life of Ernest Everett Just New York: 
Oxford University Press; 1983. 
10. Angelou Maya: I Know Why the Caged Bird Sings New York: Bantam Books; 
1971. 
11. Carnegie Commission on Science Technology and Government: Enabling 
the Future: Linking Science and Technology to Societal Goals Washington, 
DC, September; 1992. 
12. Shryock R: American Medical Research New York: Commonwealth Fund; 
1947. 
13. Strickland S: Politics, Science, and Dread Disease: A Short History of Medical 
Research Policy Cambridge: Harvard University Press; 1972. 
14. Rettig RA: Cancer Crusade: The Story of the National Cancer Act of 1971 
Princeton, NJ: Princeton University Press; 1977. 
15.  [http://report.nih.gov/award/trends/Inst_Char_All_2007.xls]. accessed 
July 1 2008
16.  [http://report.nih.gov/award/trends/State_Congressional/
StateOverview.cfm]. accessed July 1 2008
17. NIH Extramural Trends, Fiscal Years 1983-1992 . NIH Publication No. 93-3506, 
November 1993
18. Minority Programs Fact-Finding Team Recommendations, presented to the 
NIH Associate Director for Minority Programs, February 1992 .
19. Report of the National Institutes of Health: Opportunities for Research on 
Women's Health, Summary Report, Office of Research on Women's Health, 
Office of the Director, National Institutes of Health, NIH Publication No. 92-
3457A, September 1992 .
20. Fee E: Women and Health: The Politics of Sex in Medicine Farmingdale, NY: 
Baywood Publishing Company; 1983. 
21. Martin E: The Woman in the Body Boston: Beacon Press; 1989. 
22. Nelkin D, Tancredi L: Dangerous Diagnostics: The Social Power of Biological 
Information New York: Basic Books; 1989. 
23.  [http://www.voanews.com/english/2008-06-17-voa39.cfm]. accessed 
July 1 2008
24. National Center for Health Statistics: Center for Disease Control and 
Prevention, Public Health Service.  U.S. Department of Health and Human 
Services, "Health United States 1992," DHHS Pub. No. PHS 93-1232 .
25. Senate Turns Up the Heat on NSF.  Science 1993, 261:1512-1513.
26. Memo Backs Basic Research with Words, Not Cash.  Science 1994, 
264(3):1395-96.
27. Department of Health and Human Services Public Health Service, 
"Healthy People 2000," conference edition.  1990.
Received: 16 September 2008 Accepted: 7 June 2010 
Published: 7 June 2010
This article is available from: http://www.health-policy-systems.com/content/8/1/18© 2010 Cozzens; licensee BioMed Central Ltd. is an Op  Ac s  article distributed un er the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Health Research Policy and Systems 2010, 8:18
Cozzens Health Research Policy and Systems 2010, 8:18
http://www.health-policy-systems.com/content/8/1/18
Page 13 of 1328.  [http://www.healthypeople.gov]. accessed July 1 2008





infrastructure_biomedical_research_centres.aspx]. accessed January 1 
2010
32. Cozzens S, Popper S, Bonomo J, Koizumi K, Flanagan A: Methods for 
Evaluating Fundamental Science Washington, DC: Critical Technologies 
Institute, Rand Corporation; 1994. 
33.  [http://copr.nih.gov/]. accessed July 6 2008
34.  [http://copr.nih.gov/reports/enhancing.pdf]. accessed July 6 2008
35.  [http://www.invo.org.uk]. accessed September 6 2008
doi: 10.1186/1478-4505-8-18
Cite this article as: Cozzens, Quality of life returns from basic research Health 
Research Policy and Systems 2010, 8:18
